WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000063396) METHOD FOR ENHANCING MYOBLAST MIGRATION AND INVASION IN THE CONTEXT OF GENE THERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/063396    International Application No.:    PCT/US2000/003409
Publication Date: 26.10.2000 International Filing Date: 09.02.2000
Chapter 2 Demand Filed:    24.10.2000    
IPC:
C12N 15/09 (2006.01), A61K 35/34 (2006.01), A61K 48/00 (2006.01), A61P 21/00 (2006.01), A61P 21/04 (2006.01), A61P 43/00 (2006.01), C12N 15/50 (2006.01), C12N 5/02 (2006.01), C12N 5/077 (2010.01), C12N 5/10 (2006.01), A61K 35/12 (2006.01)
Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN [US/US]; 3003 South State Street, Ann Arbor, MI 48109-1280 (US) (For All Designated States Except US).
KURACHI, Kotoku [US/US]; (US) (For US Only)
Inventors: KURACHI, Kotoku; (US)
Agent: CARROLL, Peter, G.; Medlen & Carroll, LLP, 101 Howard Street, Suite 350, San Francisco, CA 94105 (US)
Priority Data:
09/293,125 16.04.1999 US
Title (EN) METHOD FOR ENHANCING MYOBLAST MIGRATION AND INVASION IN THE CONTEXT OF GENE THERAPY
(FR) PROCEDE POUR ACCROITRE LA MIGRATION ET L'INVASION DES MYOBLASTES EN THERAPIE GENIQUE
Abstract: front page image
(EN)A novel, empirically derived composition of cytokines and myoblasts is described, that allows for the migration of myoblasts through connective barriers, along with methods employing the composition in the $i(in vivo) migration of myoblasts for therapeutic purposes and gene therapy, as well as methods for the identification of agents that are agonistic or antagonistic to myoblast migration $i(in vitro) or $i(in vivo).
(FR)La présente invention concerne une nouvelle composition de cytokines et de myoblastes, obtenue de façon empirique, qui permet la migration des myoblastes à travers des barrières conjonctives. En outre, cette invention concerne des procédés qui utilisent cette composition dans la migration $i(in vivo) des myoblastes à des fins thérapeutiques et en thérapie génique, et concerne également des procédés d'identification d'agents agonistes ou antagonistes de la migration de myoblastes $i(in vitro) ou $i(in vivo).
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)